Drug Type Synthetic peptide |
Synonyms Long-Acting Urocortin 2 Analog(Sciwind Biosciences) |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Obesity | Preclinical | China | 23 Jun 2025 |






